Alice Greene MD Medical Director of Clinical Documentation Integrity Thrombophilia is synonymous with hypercoaguable state Hypercoaguable state unspecified codes to D6859 which is a CC There are specific codes for the conditions listed below which are all CCs ID: 1036455
Download Presentation The PPT/PDF document "Everything you ever wanted to know about..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Everything you ever wanted to know about DVT/PE ….. but were afraid to askAlice Greene, MDMedical Director of Clinical Documentation Integrity
2.
3. Thrombophilia is synonymous with “hypercoaguable state.”Hypercoaguable state unspecified codes to D68.59 which is a CC.There are specific codes for the conditions listed below which are all CC’s.
4. Patients can be in a “hypercoagulable state” secondary to any of the following acquired risk factors. This is a query opportunity for a CC if the patient develops a DVT or PE.
5.
6.
7.
8.
9. DOAC’s are not approved for the prevention of DVT/PE.
10.
11.
12.
13.
14.
15.
16.
17. Wells CriteriaHigh risk (≥3)Moderate risk (1-2)Low risk (0)
18.
19.
20. D-Dimer is negative…..
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31. Any DVT from popliteal and above is considered a proximal DVT. Any DVT below the knee is considered a calf/distal DVT. Calf/distal DVT’s (I82.4Z) are excluded from PSI 12 – perioperative DVT/PE rate as they are considered low risk for PEBe sure to dig deeper on any cases coded as unspecified DVT (I82.40) to determine the affected vein. Review the Doppler to determine if it was it a DVT of a proximal or distal/calf deep vein.Make sure the thrombosis is not in a superficial vein. They code as “superficial vein thrombosis of LE (182.81). These are NOT DVT’s.
32. Typically, an acute DVT is considered a new thrombosis that requires the initiation of anticoagulant therapy (perhaps, up to 3 months of treatment, but no consensus).A chronic DVT is an old or previously diagnosed thrombus that requires continuation of anticoagulation therapy. Both acute and chronic DVT’s are CC’s.In the coding rules, there are no specific timelines for when DVT or any other condition becomes chronic. The assignment of acute verses chronic DVT should be based on provider documentation
33. Dabigatran (Pradexa)*Rivaroxaban (Xerelto)Apixaban (Eliquis)Edoxaban (Savaysa)*only one with an antidote
34.
35. Bleeding while on anticoagulantBleeding is potential complication of all anticoagulants, both old and new.Patients on anticoagulants may present with:EpistaxisHemoptysisHematuria, especially in patients with indwelling Foley catheterGI bleeding with hematemesis, BRBPR, or melenaMenorrhagia in femalesHematoma (i.e. retroperitoneal, significant hematoma of the groin following cardiac catheterization that requires intervention)Hemorrhagic CVA, SAH, or subdural hematoma
36. Bleeding while on anticoagulantCoding Clinic, First Quarter ICD-10, 2016Should bleeding due to therapeutic anticoagulant be coded as a hemorrhagic disorder?Answer:For the most part, “hemorrhagic disorder” or “coagulation defects” must be specifically diagnosed and documented by the provider, in order to assign codes at category D68, Other coagulation defects. However, for bleeding such as hemoptysis, hematuria, hematemesis, hematochezia, etc., that is associated with a drug, as part of anticoagulation therapy, assign code D68.32, Hemorrhagic disorder due to extrinsic circulating anticoagulants. This is supported by the inclusion term at D68.32 of “Drug-induced hemorrhagic disorder.”This code is a CC.Although it does not require an explicit linkage by the physician, to facilitate recognition by the coder, a query could help establish the relationship.
37.
38. Query opportunity for “acute core pulmonale”
39. Not recommended for treatment of acute DVT in combination with anticoagulation.
40.
41. Anticoagulation reduces risk of recurrent VTE by 90%, low dose ASA by 30%.
42.